about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationProphylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationDifferent doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationProphylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantationGuidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets.Platelet transfusions for patients with haematological malignancies: who needs them?Thrombocytopenia-Platelet Support or Growth Factors?Use of platelet concentrate in eastern Ontario.A platelet release defect induced by aspirin or penicillin G does not increase gastrointestinal blood loss in thrombocytopenic rabbits.Procoagulant effect of incompatible platelet transfusions in alloimmunized refractory patients.Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.Hematological support of a cancer patient.Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases.Hemostatic defects in cancer patients.Disorders of platelet function: mechanisms, diagnosis and management.In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates.Cold platelets for trauma-associated bleeding: regulatory approval, accreditation approval, and practice implementation-just the "tip of the iceberg".
P2860
Q24186359-3C34CE4D-729B-4211-B948-59F261709D11Q24186913-D782EA55-2484-4086-8C51-DA99C3D3B1C0Q24187751-8FF54B6F-2EC9-42AC-A9FF-70EECC60C130Q24197779-D201DDF6-2586-47F0-90A3-CD2E6FBB1F86Q24198288-6E758405-ACC9-4BB2-8C70-CE43AC08BE3BQ24198774-BCAE4B92-4F58-4587-B176-C5061C2AD393Q24198795-D3B21A0F-2C3F-4D7D-89E6-43848D48C512Q24198832-9B529D83-59C7-443E-86D0-B0F8FB936234Q24245960-E2C859A6-522D-480D-AB43-4CC17A183262Q33351618-ECECACAC-32EA-48D4-B956-806C3A407882Q33369562-5EA0763D-2CAF-4BD8-B666-4A86DCE72D2BQ33373149-A21E6EEF-F370-47AF-9BCC-D46F580CDCE8Q33395509-F2B50B49-2B28-423F-B765-BFC2B49889ADQ33433930-CF037D85-E629-474F-9B8C-E20D4BEDC3C6Q33454292-3860AC00-A9C4-44A5-A2F0-683CD6CACB9EQ33479897-2068E6ED-944F-49BC-9428-60922126032BQ33497317-0B7E2768-FEE2-418C-85EE-AB8AE3E17C19Q34777779-43B5C061-AE2C-4A1B-9E8F-C8BF6140D218Q36415170-CCFE0B37-64AE-4E3D-8450-637535B44888Q36467280-ACCC8BCB-0038-4EAC-B0D1-A6E60C5CA93EQ39127942-269005C1-676B-4E41-BCAC-FFED05554ED4Q39345812-24F278A9-0FFD-4DC4-97F3-5EBEE8686BB9Q42116021-0ED57E62-DB63-4E5B-B4F4-12E537042DD8Q47961297-A4108B06-997E-4821-A749-A4F7F169BE89
P2860
description
1980 nî lūn-bûn
@nan
1980 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Controversies in platelet transfusion therapy.
@ast
Controversies in platelet transfusion therapy.
@en
type
label
Controversies in platelet transfusion therapy.
@ast
Controversies in platelet transfusion therapy.
@en
prefLabel
Controversies in platelet transfusion therapy.
@ast
Controversies in platelet transfusion therapy.
@en
P1476
Controversies in platelet transfusion therapy.
@en
P2093
Slichter SJ
P304
P356
10.1146/ANNUREV.ME.31.020180.002453
P577
1980-01-01T00:00:00Z